Overexpression of MicroRNA-16 Alleviates Atherosclerosis by Inhibition of Inflammatory Pathways

Table 2

Comparison of clinical characteristics between two groups.

Characteristics	Controls ()	CAD patients ()	value
Age (years)			0.101
BMI (kg/m^2)			0.211
Current smoking, (%)	18 (45.0)	27 (67.5)	0.043
Hypertension, (%)	25 (62.5)	30 (75.0)	0.228
DM, (%)	9 (22.5)	14 (35.0)	0.217
PLT (10^9/L)			0.666
Cr (μmol/L)			0.316
ALT (U/L)			0.956
AST (U/L)			0.374
TC (mmol/L)			0.679
TG (mmol/L)			0.354
HDL-C (mmol/L)			0.200
LDL-C (mmol/L)			0.001
LVEF (%)			0.006

CAD: coronary artery disease; BMI: body mass index; DM: diabetes mellitus; PLT: blood platelet; Cr: creatinine; ALT: alanine aminotransferase; AST: aspartate transaminase; TC: total cholesterol; TG: total glyceride; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; LVEF: left ventricular ejection fractions. Data are presented as the or number (%). .